Stay updated on IDO Inhibitor with Checkpoint Inhibitors for Melanoma Clinical Trial
Sign up to get notified when there's something new on the IDO Inhibitor with Checkpoint Inhibitors for Melanoma Clinical Trial page.

Latest updates to the IDO Inhibitor with Checkpoint Inhibitors for Melanoma Clinical Trial page
- Check6 days agoChange DetectedAdded Georgia, Iowa, Minnesota, New Mexico, Pennsylvania, and Utah locations and updated the record revision to v3.3.3; previous location entries from v3.3.2 were removed.SummaryDifference0.7%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2. No substantive changes to study details or page content are evident.SummaryDifference0.1%

- Check41 days agoChange DetectedThe notice about government funding lapse and NIH operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check63 days agoChange DetectedNo additions or deletions were detected; the page content appears unchanged.SummaryDifference0.3%

- Check84 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference3%

- Check91 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes provided.SummaryDifference0.1%

Stay in the know with updates to IDO Inhibitor with Checkpoint Inhibitors for Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IDO Inhibitor with Checkpoint Inhibitors for Melanoma Clinical Trial page.